Current status of cannabis regulation in Morocco
Laboratory of Drug Science, Biomedical Research and Biotechnology, Faculty of Medicine and pharmacy, Hassan II University-Casablanca, Morocco.
Review
World Journal of Biology Pharmacy and Health Sciences, 2023, 15(02), 151–156
Article DOI: 10.30574/wjbphs.2023.15.2.0350
Publication history:
Received on 01 July 2023; revised on 14 August 2023; accepted on 17 August 2023
Abstract:
Cannabis sativa L. is known for its psychotropic properties as well as therapeutic benefits, which have been exploited since ancient times. These are due to molecules synthesized within the plant known as cannabinoids, with tetrahydrocannabinol (THC) being responsible for the main effects. These products have significant therapeutic advantages related to relieving nausea and vomiting, as well as stimulating appetite. Recent evidence clearly demonstrates analgesic and antispasmodic effects that will prove clinically significant.
The global regulatory landscape regarding the medical use of cannabis is rapidly evolving, as seen in the case of Morocco, which has given the green light for cannabis use through the adoption of a new law, 13.21, that will regulate the entire production chain by establishing a national regulatory agency. It is within this context that our work is framed, with the primary objective is to providing an overview of the new cannabis regulation in Morocco. This regulatory framework will oversee all operations related to cannabis use, from production to commercialization
Keywords:
Cannabis; Regulation; Law; Morocco; National Agency
Full text article in PDF:
Copyright information:
Copyright © 2023 Author(s) retain the copyright of this article. This article is published under the terms of the Creative Commons Attribution Liscense 4.0